A significant advancement in the treatment of cystic fibrosis has been announced, bringing renewed hope for individuals affected in New Zealand. This new funding initiative represents a promising step towards…

India is currently presented with a narrow 15-20-year window to capitalise on its existing demographic dividend. Following the early 2040s, the working-age cohort aged between 15 and 59 years, which…

Recent discussions in Congress could have significant repercussions for Puerto Rico's economy. Lawmakers are contemplating the introduction of price controls on prescription drugs, similar to those seen in European nations.…

Pieris Pharmaceuticals (ISIN: US72016P1057) is garnering attention as its lead candidate, Cinrebafusp alfa, advances into phase 2 trials for HER2-positive gastric cancer, indicating potential progress in immunotherapy. Investors, particularly from…

The National Institute of Pharmaceutical Education and Research (NIPER) has announced a new opportunity for professionals in the pharmaceutical sciences. Recognised as the first national-level institute in this field, NIPER…

Tokyo – A recent discovery of novel flatworms thriving at a remarkable depth of 6,200 meters beneath the Pacific Ocean marks a significant advancement in marine biology. This finding not…

ROCHESTER — Cytotheryx, an emerging biotechnology company focused on developing treatments for liver disease, has recently completed the acquisition of the two Rochester facilities it currently occupies for a total…

Ahmedabad, Gujarat, India – Business Wire India Zydus Lifesciences Limited, a global leader in innovation within the life sciences sector, has launched Semaglutide Injection in India, marketed under the brand…

BORDEAUX, France - Aelis Farma (Euronext Paris: AELIS) has officially commenced recruitment for its Phase 2B clinical trial evaluating AEF0217 in patients diagnosed with Down syndrome. This initiative spans France,…